SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-037053
Filing Date
2024-08-14
Accepted
2024-08-14 08:08:37
Documents
19
Period of Report
2024-08-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20240814.htm   iXBRL 8-K 34919
2 EX-99.1 aqst-pressreleasefinalx8.htm EX-99.1 14002
6 aqst-pressreleasefinalx8001.jpg GRAPHIC 132243
7 aqst-pressreleasefinalx8002.jpg GRAPHIC 149192
8 aqst-pressreleasefinalx8003.jpg GRAPHIC 157535
9 aqst-pressreleasefinalx8004.jpg GRAPHIC 169279
10 aqst-pressreleasefinalx8005.jpg GRAPHIC 123079
  Complete submission text file 0001628280-24-037053.txt   1189081

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20240814.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20240814_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20240814_pre.xml EX-101.PRE 12504
21 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20240814_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 241204281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)